the present invention relates to a compound of formula i wherein r 1 , r 2 , r 3 , ar , and n are as defined herein or to a pharmaceutically active acid addition salt . compounds of formula i show a high affinity simultaneously to both the nk1 and the nk3 receptors , useful in the treatment of schizophrenia .